IDERA PHARMACEUTICALS INC's ticker is and the CUSIP is 45168K905. A total of 2 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $13,000 | -43.5% | 34,100 | -31.4% | 0.00% | – |
Q2 2022 | $23,000 | +187.5% | 49,700 | +208.7% | 0.00% | – |
Q1 2022 | $8,000 | -66.7% | 16,100 | -62.2% | 0.00% | – |
Q4 2021 | $24,000 | -59.3% | 42,600 | -25.0% | 0.00% | – |
Q3 2021 | $59,000 | -37.2% | 56,800 | -27.6% | 0.00% | – |
Q2 2021 | $94,000 | -2.1% | 78,500 | +6.2% | 0.00% | – |
Q1 2021 | $96,000 | +9500.0% | 73,900 | +18375.0% | 0.00% | – |
Q4 2020 | $1,000 | -75.0% | 400 | -80.0% | 0.00% | – |
Q3 2020 | $4,000 | -63.6% | 2,000 | -68.3% | 0.00% | – |
Q2 2020 | $11,000 | 0.0% | 6,300 | -21.2% | 0.00% | – |
Q1 2020 | $11,000 | -72.5% | 8,000 | -63.6% | 0.00% | – |
Q4 2019 | $40,000 | -39.4% | 22,000 | -4.3% | 0.00% | -100.0% |
Q3 2019 | $66,000 | +65.0% | 23,000 | +48.4% | 0.00% | – |
Q1 2019 | $40,000 | +207.7% | 15,500 | +237.0% | 0.00% | – |
Q4 2018 | $13,000 | -95.5% | 4,600 | -85.9% | 0.00% | -100.0% |
Q3 2018 | $290,000 | – | 32,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 8,000 | $11,000 | 0.00% |